Comparison of Toxoplasma and Rubella seropositivity rates of Syrian and Turkish pregnant women
Öz
Purpose: Toxoplasma gondii, rubella and cytomegalovirus (TORCH) infections are the leading causes of perinatal morbidity and mortality, especially in developing countries. This study aimed to compare the seroprevalence of Toxoplasma and Rubella in Turkish pregnant women and Syrian refugee pregnant women, whose number is increasing in our region.
Materials and Methods: Syrian and Turkish pregnant women between the ages of 18 and 49 who were admitted to a secondary care hospital for their first prenatal visit between March 2018 and November 2019 were included in this retrospective study. Age, gravida, parity, nationality and anti-T. gondii IgM, anti-T. gondii IgG, anti-Rubella IgM, and anti-Rubella IgG test results of the patients included in the study were retrospectively recorded from the hospital archive and compared.
Results: Out of 3,606 pregnant women included in the study, 2,768 (76.7%) were Turkish and 838 (23.3%) were Syrian. Anti-T. gondii IgM positivity rate (6.1%) of Syrian pregnant women was significantly higher than the rate (2.1%) of Turkish pregnant women. Although Anti-Rubella IgG positivity was not statistically significantly different it was higher in Turkish pregnant women (85.2% and 88.7% respectively).
Conclusion: Knowing the incidence and prevalence of toxoplasma and rubella infection in pregnant women plays a critical role in determining the burden of the disease, planning screening programs, and active use of primary healthcare services. Screening programs in antenatal care for toxoplasma and rubella should especially be planned in regions that provide healthcare by considering the increasing number of Syrian refugees.
Anahtar Kelimeler
pregnancy, rubella, seroprevalence, Syrian refugees, toxoplasma gondii
Kaynakça
- 1. Bahat PY, Turan G, Özgör BY, et al. Comparison of hepatitis B, hepatitis C, and HIV seropositivity of Syrian and Turkish pregnant women. Turkish journal of obstetrics and gynecology. 2019;16(2):95.
- 2. Doğan K, Kafkaslı A, Karaman Ü, et al. Gebelerde Toksoplazma enfeksiyonunun seropozitiflik ve serokonversiyon oranları. Mikrobiyol Bul. 2012;46(2):290-294.
- 3. Topçu AW SG, Doğanay M, ed. . Toxoplasma gondii. . İnfeksiyon Hastalıkları ve Mikrobiyolojisi. Vol. 2015. İstanbul: Nobel Tıp Kitabevleri. p. s.1883–97.
- 4. Montoya JG KJ, Remington JS. . Toxoplasma gondii. . Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 6th ed. . Vol. 2005: Philadelphia: Elsevier Churchill Livingstone. p. 3170–98.
- 5. https://gocvakfi.org/tr/2019/11/20/2020-yili-cumhurbaskanligi-yillik-programi-aciklandi/[cited 20.05.2020].
- 6. Cherri Z, Gil Cuesta J, Rodriguez-Llanes JM, et al. Early marriage and barriers to contraception among Syrian refugee women in Lebanon: a qualitative study. International journal of environmental research and public health. 2017;14(8):836.
- 7. CENGİZ SA, CENGİZ L, Ebru U, et al. GEBE KADINLARIN SERUMLARINDA RUBELLA IgG VE IgM’NİN ELISA İLE ARAŞTIRILMASI. İnfeksiyon Dergisi (Turkish Journal of Infection). 2005;19(1):19-24.
- 8. Paquet C, Yudin MH, Allen VM, et al. Toxoplasmosis in pregnancy: prevention, screening, and treatment. Journal of obstetrics and gynaecology Canada. 2013;35(1):78-79.
- 9. SARAÇOĞLU F, ŞAHİN İ. Gebe Populasyonunda Toksoplazma Prevalansı ve Duyarlı Gebelerde Serolojik Dönüşüm Oranı. Journal of Clinical Obstetrics & Gynecology. 2001;11(5):326-328.
- 10. Çiçek AÇ, Duygu F, İnakçı İH, et al. Şanlıurfa ilinde doğurganlık çağındaki kadınlarda ELISA ile Toxoplasma gondii antikorlarının araştırılması: Üç yıllık değerlendirme. J Clin Exp Invest. 2012;3.
